Tag archive for ‘MRK’
By Mike Cantrell On Monday, April 24th, 2017
0 Comments

Merck & Co. (NYSE:MRK) Releases Presentation of Findings from a Retrospective Database Analysis of Patients With Chronic HCV Infection

Merck & Co., Inc. (NYSE:MRK) felling -1.06% to trade at $61.89. On the relative analysis with scale of 1-5, firm standing at analysts’ recommendation of 2.30. Volatility makes major charm for active investors, More...

By Evan Cavise On Monday, April 24th, 2017
0 Comments

Major Development in Views: Wells Fargo (NYSE:WFC), Merck & Co. (NYSE:MRK), WABCO Holdings (NYSE:WBC)

Wells Fargo & Company (NYSE:WFC) slummed -0.93% to settle at $53.00 with the total traded volume of 26.16 Million shares. Wells Fargo (WFC) declared that extension of its class-action settlement for retail More...

By Rebecca Wien On Thursday, April 20th, 2017
0 Comments

Merck & Co. (NYSE:MRK) Researchers Are Slated To Provide More Than 25 Scientific Data Presentations

Merck & Co., Inc. (NYSE:MRK) are increasing 0.59% to trade at $62.64. On the relative analysis with scale of 1-5, firm standing at analysts’ recommendation of 2.30. Volatility makes major charm for active More...

By Rebecca Wien On Wednesday, April 12th, 2017
0 Comments

Most Active Drug Manufacturers: Merck & Co., Inc. (NYSE:MRK), Bristol-Myers Squibb Company (NYSE:BMY)

Merck & Co., Inc. (NYSE:MRK) shrank -0.08% to settle at $62.50 with the total traded volume of 3.73 Million shares. Merck (MRK) declared that Dr. John H. Noseworthy, president and chief executive officer of More...

By Roger Goldfarb On Tuesday, April 11th, 2017
0 Comments

Apple Inc. (NASDAQ:AAPL) Declares iPhone 8 Is Still Months Away, But Leaks Are In Abundance

Apple Inc. (NASDAQ:AAPL) stock moved down -2.00% to the trading price of $140.31. Apple’s (AAPL) declared that iPhone 8 is still months away, but leaks are in abundance. The latest one reiterates claims of More...

By Mike Cantrell On Monday, April 10th, 2017
0 Comments

Merck & Co (NYSE:MRK) Receives Complete Response Letter Regarding Merck’s Supplemental New Drug Applications

Merck & Co., Inc. (NYSE:MRK) are lagging behind -0.06% to trade at $63.13. Volatility makes major charm for active investors, so firm has 1.01% volatility for month and its performance in stock market being More...